🇺🇸 FDA
Pipeline program

Irinotecan Hydrochloride Liposome Injection;Carboplatin Injection;Serplulimab Injection

ES-2024-072-02

Unknown small_molecule active

Quick answer

Irinotecan Hydrochloride Liposome Injection;Carboplatin Injection;Serplulimab Injection for Small Cell Lung Cancer is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Small Cell Lung Cancer
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials